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Abstract
The platelet integrin KIIbL3 exhibits bidirectional signaling, in that intracellular messengers enable adhesive
macromolecules to bind to its ectodomain, while ligation promotes the association of cytoskeletal proteins with its
cytoplasmic domains. In order to understand the linkage between these distant regions, we investigated the effects of receptor
occupancy on the solution structure of both full-length recombinant KIIbL3 and KIIbv991L3, an integrin truncation mutant
which lacks one cytoplasmic domain. Lysates of 35S-labeled human A549 cells expressing either full-length KIIbL3 or
KIIbv991L3 were examined by sucrose density gradient sedimentation followed by immunoprecipitation to determine the
distributions of integrin protomers and oligomers. Recombinant KIIbL3 exhibited a weight-average sedimentation
coefficient, Sw = 11.3 þ 1.4 S with 73% sedimenting as protomers/dimers (9.1 þ 1.0 S) and 27% as oligomers (15.4 þ 0.4 S).
Truncation mutant KIIbv991L3 exhibited a similar pattern with 65% sedimenting as protomers/dimers. Upon ligation with
eptifibatide, both full-length KIIbL3 and KIIbv991L3 sedimented mainly at s 14 S, indicating 2^3-fold increased
oligomerization. Thus we have demonstrated that KIIb’s cytoplasmic region is not required for integrin clustering, a key
event in outside-in signaling. ß 2001 Elsevier Science B.V. All rights reserved.
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1. Introduction
Integrins are a family of heterodimeric membrane-
spanning proteins that serve as nature’s cradle-to-
grave receptors, regulating essential cellular processes
ranging from embryonic development to pro-
grammed cell death [1^4]. Aberrant integrin function
also contributes to many disease processes, including
thrombosis, in£ammation, and tumor cell metastasis
[5^7]. The KIIbL3 integrin, present at high density on
the surface of human blood platelets [8], provides a
paradigm for understanding the structure/function
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relationships of the integrin family [9,10]. Termed the
‘responsive integrin’ [11], KIIbL3 must be activated
to enable high-a⁄nity interactions with its primary
ligand, ¢brinogen, in a process that is required for
normal hemostasis [12].
Physiological integrin activation pathways, termed
‘inside-out’ signaling, can be initiated by occupancy
of G-protein-coupled platelet receptors for ADP or
thrombin [13,14]. Subsequent steps that involve cal-
cium £uxes, phosphorylation events and intracellular
interactions with integrin-associated proteins are
considered to yield changes in KIIbL3 conformation
and aggregation state that modulate the receptor’s
a⁄nity and avidity [15,16]. Binding macromolecular
adhesive ligands such as ¢brinogen, ¢bronectin or
von Willebrand factor to these activated integrins
triggers receptor clustering, focal adhesion kinase
stimulation, and interactions with cytoskeletal pro-
teins in a process termed ‘outside-in’ signaling
[15,16].
The structural bases of inside-out activation are
the subject of active investigation [17^19]. Key in-
sights have come from the observations that truncat-
ing either of the short cytoplasmic domains found at
the carboxy-termini of the KIIb and L3 polypeptide
chains produces constitutively active integrins that
can bind ¢brinogen tightly even without exposure
to a cellular stimulus [20,21]. Recently, NMR struc-
tural studies and molecular modeling of the confor-
mation and interactions of these cytoplasmic do-
mains have led to a model that may explain how
information is transmitted over distances s 10 nm
to KIIbL3’s extracellular domain, the region that har-
bors the binding site(s) for adhesive macromolecules
[22,23]. In parallel, we have de¢ned the mechanism
of outside-in signaling by showing that ligand-mim-
etic peptides directed to each integrin subunit trigger
a large conformational change in the receptor’s
ectodomain that increases its frictional drag, result-
ing in decreases in both its sedimentation and di¡u-
sion coe⁄cients [24,25]. We have also shown that
epti¢batide, a ligand-mimetic that occupies KIIbL3’s
¢brinogen binding site [26,27], is especially e¡ec-
tive at enhancing oligomerization through the recep-
tor’s transmembrane and/or cytoplasmic domains
[25].
Thus we hypothesized that both inside-out and
outside-in integrin activation mechanisms were
linked, possibly through a mechanical coupling of
the type proposed by Koshland and colleagues [28]
who envisioned that a scissors-like opening of the
ectodomain of a two-subunit receptor could be trans-
mitted across its membrane spanners to a distant
cytoplasmic domain. A molecular machine of this
type could also work in reverse, sending conforma-
tional changes initiated in the cytoplasmic domain
outward toward the receptor’s extracellular binding
site [21,29,30]. Application of these concepts to in-
tegrin cytoplasmic domain truncation mutants sug-
gests integrins that are constitutively active for in-
side-out signaling might also be constitutively active
for outside-in signaling. If so, they should display an
increased frictional drag due to the open architecture
of their ectodomains, even in the absence of ligands
[13,24,31,32]. We further hypothesized that receptor
self-association mediated by the now unpaired cyto-
plasmic domain would also follow, again independ-
ent of ligand binding.
This study was initiated to test these concepts, us-
ing a truncation mutant, KIIbv991L3, in which the
carboxy-terminal 18 residues that follow residue 990
have been deleted [20]. This mutant was previously
shown to be constitutively active for ¢brinogen bind-
ing when expressed in CHO cells [20,21]. Here we
have determined the sedimentation velocity pro¢les
of detergent-solubilized wild-type and mutant integ-
rins by sucrose density gradient centrifugation [33], a
technique sensitive to conformational changes and
receptor self-association. We will demonstrate that
KIIb’s cytoplasmic domain is not required for li-
gand-induced integrin clustering. This implies that
inside-out and outside-in signaling are structurally
distinct processes. Thus our ¢nding provide new in-
sights into the structural changes responsible for in-
tegrin activation and signaling.
2. Experimental procedures
2.1. Reagents
Monoclonal antibodies speci¢c for KIIb (MAB
1990 [34]) and L3 (MAB 1381) and £uorescein-con-
jugated goat-antimouse IgG were purchased from
Chemicon International (Temecula, CA). Monoclo-
nal antibody CD41-PE, speci¢c for the KIIbL3 com-
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plex [35] and labeled with phycoerythrin, was pur-
chased from Immunotech (Mareseille, France). Pro-
tein A-Sepharose was purchased from Sigma Chem-
ical (St. Louis, MO). Highly puri¢ed human
¢brinogen was purchased from American Diagnosti-
ca (Greenwich, CT). Oregon Green isothiocyanate
and a Texas Red-X Protein Labeling kit were pur-
chased from Molecular Probes (Eugene, OR). Myo-
globin, phosphorylase and urease were purchased
from Sigma Chemical. Epti¢batide (Integrilin) was
kindly provided by COR Therapeutics (South San
Francisco, CA), ¢bronectin by Dr. Stefan Handt
(Aachen, Germany) and hemoglobin by Dr. D.
Kim-Shapiro (Winston-Salem, NC). KIIbL3 was pu-
ri¢ed from outdated human blood platelets (Ameri-
can Red Cross, Charlotte, NC) as previously de-
scribed [36]. Membrane fractions enriched in
KIIbL3 were isolated by di¡erential centrifugation
from blood obtained from healthy, adult volunteer
donors as previously described [37].
2.2. Cloning and expression of KIIbL3 and
KIILv991L3
cDNA encoding the KIIb and L3 subunits were
generously provided by Dr. J. Bennett [38] and Dr.
D. Phillips [39], respectively. Each cDNA was sub-
cloned into plasmid pGEM-3Z (Promega) under con-
trol of the bacteriophage T7 promoter. However,
DNA sequence analysis identi¢ed a gap in the
cDNA sequence encoding the KIIb subunit corre-
sponding to nucleotide positions 2871^2972. The
missing cDNA sequence was obtained by reverse
transcription (RT) and polymerase chain reaction
(PCR) using Pwo DNA polymerase (Boehringer
Mannheim) and RNA from HEL cells induced to
di¡erentiate by treatment with DMSO. The primers
used for RT^PCR were 5P-AACAGCTCCAACCC-
3P (3P primer) and 5P-ACAAGCGGGATCGCA-3P
(5P primer). The resulting cDNA was cloned between
the BglII and HindIII sites of the original KIIb se-
quence.
A similar PCR mutagenesis and fragment ex-
change procedure was used to obtain a vector ex-
pressing the truncation mutant KIIbv991. The 3P
primer 5P-CCCCAAGCTTCAGACCTTCCACAT-
GGC-3P was designed to incorporate a stop codon
and a HindIII site after codon 990, and was used
together with the 5P primer described above in a
PCR reaction with the wild-type KIIb cDNA as a
template.
2.3. Radiolabeling and immunoprecipitation of
integrins in transfected cells
A549 cells (approximately 106 cells per 60-mm
dish) were infected with a vaccinia virus recombinant
that expresses bacteriophage T7 RNA polymerase
(vTF7.3) at a multiplicity of 20 pfu/cell. At 1 h post-
infection, cells were transfected with a total of 9 Wg
of plasmid DNA and 18 Wg of Lipofectin reagent
(Gibco BRL). The DNA consisted of either equal
amounts of KIIb and L3 cDNAs or of a plasmid
(pF1SG) encoding the vesicular stomatitis virus
(VSV) envelope glycoprotein (G protein) as a nega-
tive control. Cells were incubated an additional 4 h
after transfection to allow expression of integrin
mRNA before radiolabeling. Cells were depleted of
methionine by incubation for 10 min in methionine-
de¢cient medium, then were pulse-labeled with
[35S]methionine (400 WCi/ml mixed with methionine-
de¢cient medium) for 2 h and incubated in nonra-
diolabeled medium for an additional 15 h to allow
processing, assembly and transport to the cell surface
of radiolabeled integrin subunits [40]. Cell extracts
were prepared by solubilization at 4‡C in CATT
bu¡er (1% Triton X-100R, 10 mM Tris, 0.5 mM
CaCl2, 1 WM leupeptin, 30 nM aprotinin, pH 7.4)
at approximately 6U106 cells/ml, followed by centri-
fugation at 15 000Ug for 15 min at 4‡C. Cell extracts
were either analyzed by sucrose gradient centrifuga-
tion followed by immunoprecipitation of gradient
fractions, or else were analyzed directly by immuno-
precipitation of KIIb and L3 subunits. Cell extracts
or gradient fractions were incubated for 2 h at 4‡C
with one of the following monoclonal antibodies:
anti-KIIb MAB 1990 at 2 Wg/ml, anti-L3 MAB
1381 at 5 Wg/ml or anti-G (MAB I1) at a 1:300
dilution [41]. The resultant immune complexes were
incubated with Protein A Sepharose (1:5 dilution)
for 1 h at 4 C, then centrifuged for 2 min at
15 000Ug followed by six washes with 300 Wl
CATT bu¡er. Pellets were incubated with 25 Wl of
SDS disruption bu¡er (4% SDS, 44% glycerol, 2%
2-mercaptoethanol, 0.1% bromophenol blue), boiled
for 2 min to solubilize the samples and subjected to
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sodium dodecyl sulfate^polyacrylamide gel electro-
phoresis (SDS^PAGE). Each gel also contained
14C-labeled standard proteins (Amersham Pharmacia
Biotech, Piscataway, NJ) for molecular mass calibra-
tion. The dried gels were incubated in a Phosphor
Imager cassette (Molecular Dynamics) for 4^24 h
followed by detection with a PhosphorImager 445
SI (Molecular Dynamics). Molecular masses were
determined from a standard curve constructed
and analyzed with SigmaScan software (Jandel
Scienti¢c, San Rafael, CA). Band intensities were
measured with Image QuaNT software (Molecular
Dynamics).
2.4. Flow cytometric analysis
Approximately 1U106 A549 cells were transfected
with plasmids encoding each of the following pro-
teins: KIIb and L3, KIIbv991 and L3, or the VSV
G protein. At 24 h post-transfection, cells were
washed twice with ice-cold PBS, then were incubated
for 60 min in the dark on ice with a KIIbL3 complex-
speci¢c monoclonal antibody, labeled with the £uo-
rophore phycoerythrin (CD41-PE, diluted 50-fold as
recommended by Immunotech, Marseille). This anti-
body reacts with the KIIb heavy chain in the intact
KIIbL3 complex, but not with either subunit sepa-
rately [35]. The VSV G protein-expressing cells
served as a negative control for nonspeci¢c staining
with CD41-PE. Cells expressing VSV G protein were
also incubated with anti-G monoclonal antibody I1
[41] (diluted 300-fold) to provide a positive control
for G-protein expression; cells expressing KIIbL3
were similarly treated with I1 to provide a negative
control. Following two washes with PBS containing
0.1 M glycine and 10% bovine serum albumin (PBS-
Glycine-BSA) these cells were incubated with £uores-
cein-labeled goat-antimouse IgG at 10 Wg/ml (Chem-
icon International).
Following immunostaining, all cells were washed
with PBS, then ¢xed for 10 min at room temperature
with 1% formaldehyde followed by two washes with
PBS-Glycine-BSA. Cells were scraped from the cov-
erslips and resuspended in the same bu¡er at a den-
sity of V106 cells/ml. Flow cytometric analyses were
carried out in a Becton^Dickinson FACS Calibur
and the data analyzed with CellQuest software (Bec-
ton^Dickinson, San Jose, CA).
2.5. Laser scanning confocal microscopy
Microscope coverslips coated with near-con£uent
cultures of A549 cells transfected with plasmids en-
coding each of the following proteins: KIIb and L3,
KIIbv991 and L3, or the VSV G protein were washed
twice with phosphate-bu¡ered saline (PBS), then
¢xed for 30 min at room temperature with 4% form-
aldehyde followed by two washes with PBS, blocked
for 15 min with PBS containing 0.1 M glycine, then
blocked for 1 h with PBS containing 0.1 M glycine
and 10% bovine serum albumin (PBS-Glycine-BSA).
Coverslips coated with cells expressing each pair of
integrin subunits or the VSV G protein were then
incubated for 2 h with one each of the following
monoclonal antibodies: anti-KIIb MAB 1990 at
2 Wg/ml, anti-L3 MAB 1381 at 5 Wg/ml or anti-G at
a 1:300 dilution. Following three washes with PBS-
Glycine-BSA, each of these nine samples was incu-
bated with £uorescein-labeled goat-antimouse IgG
(Chemicon International) at 10 Wg/ml for 1 h, fol-
lowed by three washes with PBS-Glycine-BSA.
Each coverslip was a⁄xed to a microscope slide us-
ing Aquamount.
These same immunolabeling procedures were also
employed with samples of human blood platelets,
isolated by di¡erential centrifugation from platelet-
rich plasma [42] obtained from blood collected into
citrate anticoagulant from a healthy, adult volunteer
donor. Since platelets express high levels of the
KIIbL3 complex [11], they provided a convenient
control from which to quantify the speci¢c immuno-
£uorescent signals that resulted from binding mono-
clonal antibodies directed to the KIIb and L3 sub-
units, as well as the nonspeci¢c signal that resulted
with the anti-G antibody.
Samples were examined by laser scanning confocal
microscopy using a Zeiss LSM 510 equipped with a
63U water objective and an argon ion laser (maxi-
mum emission at 488 nm). Emitted £uorescence was
imaged using a 488-nm beam splitter and 500^550-
nm bandpass emission ¢lter. For each of the nine
samples (expressing KIIb and L3, KIIbv991 and L3,
or the VSV G protein; each labeled with either anti-
KIIb, anti-L3 or anti-G) images were collected from a
least three randomly selected ¢elds, each containing
between three and ten cells. At least nine cells were
analyzed for each condition. All images were taken
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under identical imaging conditions. The pinhole
aperture was set at 1 mm to maximize the depth of
light collection. Laser intensity, scan time and image
¢eld were all constant and set to produce linear £uo-
rescence across the intensity range seen within the
samples. The ¢eld of view was 148U148 Wm. The
images were saved as uncompressed TIFF ¢les. The
distribution of £uorescent intensities and point inten-
sity measurements were made on at least 20 ran-
domly selected areas of each cell and analyzed using
SigmaScan software (Jandel Scienti¢c).
2.6. Sucrose density gradient sedimentation
Samples containing KIIbL3 or KIILv991L3 were
separated by sucrose density gradient sedimentation
on 5^20% sucrose gradients and 30 mM octyl gluco-
side. These gradients were prepared from solutions
containing either 5 g or 20 g of sucrose dissolved in a
100 ml solution of HEPES-bu¡ered saline (pH 7.4)
that also contained 30 mM octyl glucoside, 2 mM
CaCl2, 1 WM leupeptin and 30 nM aprotinin (HSC-
OG). Each gradient was contained in a 13U51-mm
polyallomer centrifuge tube (Beckman Instruments,
Palo Alto, CA) to which a 0.2-ml cushion of 40%
sucrose in HSC-OG was ¢rst added; linear gradients
were prepared with a Density Gradient Forming Sys-
tem and Auto Densi-Flow position-sensing pump
(LabConco, Kansas City, MO) using 2.2 ml of 5%
sucrose in HSC-OG in the reservoir and 2.2 ml of
20% sucrose in HSC-OG in the mixing chamber.
Samples (typically 0.4 ml) were carefully layered
on the top of each gradient-containing tube; centri-
fugation was carried out in a Ti-55 rotor at 50 000
rpm for 5 h at 20‡C. Each gradient was fractionated
into 10^15 samples of 0.4^0.5 ml using an Auto Den-
si-Flow device coupled to a Bio-Rad Model 2128
fraction collector. The mass of each fractionated
sample was determined to control for small varia-
tions in the fractionation procedures. With samples
of puri¢ed KIIbL3 [36,37], receptor concentrations
within the gradients were determined by SDS^
PAGE carried out on disul¢de-bond reduced sam-
ples, followed by staining with Coomassie Brilliant
blue; the resultant images were captured digitally for
densitometric analysis with SigmaScan software.
With samples of platelet lysates, receptor concentra-
tions were determined by immunoblotting following
separation by SDS^PAGE and electrophoretic trans-
fer to PVDF membranes [43] using a primary mono-
clonal antibody speci¢c for the KIIb subunit (CD41;
#539, Immunotech/Coulter, Miami, FL) coupled
with a secondary alkaline phosphatase-conjugated
goat-antimouse IgG (Immun-Blot Colorimetric As-
say kit, Bio-Rad Laboratories, Hercules, CA). These
digitally captured images were also analyzed densito-
metrically with SigmaScan. Gradient samples ob-
tained with 35S-labeled transfected cells expressing
KIIbL3 or KIILv991L3 were subjected to immunopre-
cipitation with an anti-KIIb (MAB 1990, Chemicon
International) followed by phosphor imaging as de-
scribed in an earlier section.
Gradients were calibrated with a mixture of pro-
teins of known sedimentation coe⁄cient [44] con-
tained in a separate tube within the same rotor.
These proteins included myoglobin (2.0 S), hemoglo-
bin (4.2 S), Oregon Green-labeled ¢brinogen (8.05 S),
Texas Red-labeled ¢bronectin (11.5 S), Texas Red-
labeled phosphorylase (13.7 S), Texas Red-labeled
urease (19 S). Sedimentation pro¢les of these stan-
dards were obtained by measuring the A495 nm (Or-
egon Green-¢brinogen) and A595 (myoglobin, hemo-
globin, and Texas Red-labeled proteins) of 200-Wl
aliquots of each fractionated gradient in a Vmax
Microtiter Plate Reader (Molecular Devices).
3. Results
3.1. Expression of full-length and mutant integrins in
transfected cells
Human lung A549 cells were infected with a vac-
cinia virus recombinant expressing T7 RNA poly-
merase, then cotransfected with plasmids encoding
either the full-length KIIb or KIIbv991 integrin poly-
peptide, together with a plasmid encoding the L3
subunit, under control of a T7 promoter. Levels of
integrin expression were analyzed by labeling with
[35S]methionine and immunoprecipitation. Trans-
fected cells yielded substantial expression of both K
and L subunits (Fig. 1). Cells transfected with wild-
type KIIbL3 integrin cDNA showed prominent bands
at 126 þ 12 kDa and 98 þ 4 kDa (n = 6) when precipi-
tated with either an KIIb-speci¢c or a L3-speci¢c
mAb. These results are consistent with the observed
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electrophoretic mobilities of the platelet-derived gly-
cosylated polypeptides on SDS^PAGE, and they
agree reasonably well with the calculated molecular
masses for the KIIb heavy chain (111 kDa) and L3
subunit (95 kDa) [36,45]. The precipitation of the
subunit against which the antibody reacted was usu-
ally more e⁄cient than coprecipitation with the other
subunit. For example, the KIIb band was more in-
tense in the sample precipitated with anti-KIIb than
anti-L3 in Fig. 1. The speci¢city of immunoprecipi-
tation was established with an antibody that recog-
nizes the VSV G protein; this mAb precipitated less
intense bands corresponding to proteins of V103
kDa and V36 kDa (Fig. 1). Since the KIIb mAb
consistently provided a stronger signal with minimal
interference from these nonspeci¢c bands, this re-
agent was used for subsequent measurements of re-
combinant integrin concentrations in cell lysates.
Cells transfected with mutant KIIbv991L3 integrin
cDNAs displayed prominent bands at 123 þ 15 kDa
and 102 þ 10 kDa (n = 5) when precipitated with an
KIIb-speci¢c mAb or with a L3-speci¢c mAb, consis-
tent with the expected sizes for the KIIbv991 subunit
(111 kDa) and full-length L3-chain. We note that
both full-length KIIb and truncation mutant
KIIbv991 share a common heavy chain; the trunca-
tion is made in the light chain (21 kDa full-length/19
kDa truncation mutant) which is not readily visual-
ized on these reduced samples.
Fig. 1 also shows a less intense band at V150
kDa, identi¢ed as a pre-KIIb subunit that has not
yet undergone the posttranslational cleavage of
KIIb into its heavy and light chains [40]. All studies
presented here used a 2-h pulse followed by a 15-h
chase to optimize the processing of the labeled KIIb
subunit to the mature form [40]. The intensity of this
pre-KIIb band was more prominent following a 1-h
pulse label (data not shown).
Cell surface expression levels of the assembled
KIIbL3 integrin on cells transfected with plasmids
encoding either the KIIb and L3 subunits or
KIIbv991 and L3 were determined by £ow cytometric
analyses, using a phycoerythrin-conjugated, KIIbL3
complex-speci¢c monoclonal antibody [35]. Comple-
mentary data were obtained by measuring expression
levels of the individual KIIb and L3 subunits by laser
scanning confocal microscopy, using the subunit-spe-
ci¢c mAbs coupled with immunostaining with a £uo-
rescein-conjugated goat-antimouse antibody.
Fig. 2A shows £ow cytometry analysis of trans-
fected A549 cells expressing VSV G protein labeled
with an anti-G protein antibody (thin line) used as a
positive control and a negative control transfected
with a plasmid lacking the G gene, labeled with the
same antibody (thick line). Many of the transfected
cells expressed high levels of G protein. Results from
three £ow cytometric analyses, carried out with sep-
arate sets of transfected cells, indicated that
51.1 þ 3.4% of cells were positive for G protein ex-
pression. The analyses were gated such that
2.4 þ 1.6% of cells were positive with the negative
controls. These data indicate that the transfection
e⁄ciency in these experiments was quite high, so
that at least 50% of the cells expressed the VSV G
protein.
Fig. 2B shows £ow cytometry analysis of trans-
fected cells coexpressing KIIb and L3 integrin sub-
units labeled with an antibody speci¢c for the KIIbL3
complex. While there was clearly a positive signal
(Fig. 2B, thin line) indicative of KIIbL3 complex ex-
pression, the £uorescence intensity of the positive
cells was not very high, and there was signi¢cant
Fig. 1. Expression of full-length KIIbL3 and truncation mutant
KIIbv991L3 in transfected cells. Human lung A549 cells were
infected with a vaccinia virus recombinant expressing T7 RNA
polymerase, then cotransfected with plasmids encoding either
the full-length KIIb or KIIbv991L3 integrin polypeptide, togeth-
er with a plasmid encoding the L3 subunit, under control of a
T7 promoter. Detergent lysates of each transfected 35S-labeled
cell type were immunoprecipitated with an antibody speci¢c for
either KIIb, L3 or the VSV G protein (negative control) ; fol-
lowing solubilization and electrophoretic separation, radiola-
beled polypeptides were detected with a PhosphorImager 445 SI
(Molecular Dynamics). Molecular masses were determined using
14C-labeled protein markers (Amersham Pharmacia Biotech).
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Fig. 2. Immuno£uorescence measurements of integrin cell surface expression. Flow cytometry. A549 cells transfected with plasmids en-
coding each of the following proteins: KIIb and L3, KIIbv991 and L3, or the VSV G protein (negative control), were immunolabeled
with an KIIbL3 complex-speci¢c, phycoerythrin-conjugated monoclonal antibody. Cells expressing VSV G protein and KIIbL3 were
also incubated with anti-G monoclonal antibody followed by a £uorescein-labeled goat-antimouse IgG to provide positive and nega-
tive controls for G-protein expression, respectively. Cells suspended at a density of V106 cells/ml were examined by £ow cytometric
analysis in a Becton^Dickinson FACS Calibur. (A) Histographs (£uorescence intensity, counts) for VSV G expression (light trace)
and the corresponding negative control (heavy trace). (B) Histographs for full-length KIIbL3 expression (thin line) and its negative
control (¢lled curve). (D) Histographs for truncation mutant KIIbv991L3 expression (thin line) and its negative control (¢lled curve).
Laser scanning confocal microscopy. Adherent A549 cells transfected with plasmids encoding each of the following proteins: KIIb and
L3, KIIbv991 and L3, or the VSV G protein, were immunolabeled with monoclonal antibodies speci¢c for either KIIb or L3 followed
by detection with a £uorescein-labeled goat-antimouse antibody. Samples were examined with a Zeiss LSM 510 equipped with an ar-
gon ion laser (maximum emission at 488 nm) and a 63U water objective using a 1-mm pinhole aperture to maximize the depth of
light collection. Point intensity measurements were made on at least ten randomly selected areas of at least nine cells for each condi-
tion and the results analyzed with SigmaScan software (Jandel Scienti¢c). (C) Histographs (£uorescence intensity, % cell-surface areas)
for KIIb (open circles) and L3 (solid circles) obtained with cells expressing full-length KIIbL3 and the corresponding negative controls
(open and solid triangles, respectively). (E) Histographs for KIIb (open circles) and L3 (solid circles) obtained with cells expressing
truncation mutant KIIbv991L3 and the corresponding negative controls (open and solid triangles, respectively).
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overlap with the negative control (Fig. 2B, ¢lled
curve). Replicate analyses of three separate transfec-
tion experiments indicated that 8.0 þ 0.5% of cells
were positive for KIIbL3 expression compared to
1.9 þ 0.2% of the negative control. This was much
less than the 50% positive cells expected from anal-
ysis of the control cells expressing VSV G protein
(Fig. 2A). Similar results were obtained using anti-
bodies speci¢c for the individual KIIb and L3 integrin
subunits (not shown). The low percentage of cells
that expressed levels of KIIbL3 above the negative
controls was not consistent with visual images of
labeled transfected cells obtained by £uorescence mi-
croscopy, suggesting that better discrimination of
positive cells from the negative controls could be
obtained by this technique.
Integrin cell surface expression levels on cells
transfected with plasmids encoding KIIb and L3 sub-
units were also measured by quantitative immuno-
£uorescence microscopy using an KIIb or L3 sub-
unit-speci¢c monoclonal antibody, each detected
with a £uorescein-labeled secondary antibody. Fluo-
rescence intensities of individual cells were deter-
mined using a laser confocal £uorescence micro-
scope, and are shown in Fig. 2C. The data are
presented as a percent of total cell surface areas ex-
amined versus log(£uorescence intensity), to be com-
parable to the data obtained by £ow cytometry (Fig.
2B). The distribution of £uorescence intensities from
labeling of the KIIb subunit (open circles) was similar
to that of the L3 subunit (¢lled circles). Control ex-
periments in which platelets were labeled with the
same antibodies showed that the KIIb- and L3-spe-
ci¢c antibodies gave comparable £uorescence inten-
sities (not shown). Thus these data indicate that the
two subunits were expressed at comparable levels on
the surface of transfected cells. Most importantly, a
substantial percentage of cells transfected with plas-
mids encoding KIIb and L3 subunits (Fig. 2C, circles)
had £uorescence intensities higher than the negative
controls transfected with the plasmid encoding the
VSV G protein (Fig. 2C, triangles). Cumulative
data from two separate experiments indicated that
39% of cells were positive for KIIb expression
(n = 1376), 41% were positive for L3 expression
(n = 735), and 6 1% were positive in the negative
controls. These data are consistent with the high
transfection e⁄ciencies observed in cells transfected
with the plasmid encoding the VSV G protein (Fig.
2A).
Similar results were obtained with cotransfected
cells expressing the truncation mutant KIIbv991 to-
gether with the L3 subunit. Flow cytometry analysis
of transfected cells labeled with an antibody speci¢c
for the KIIbL3 complex (Fig. 2D) showed only a
small percentage with £uorescence intensities above
the negative control (4.5 þ 0.8% in three separate ex-
periments). However, quantitative immuno£uores-
cence microscopy (Fig. 2E) showed that a substantial
percentage of transfected cells were positive for
KIIbv991 and L3 subunit expression (44% positive
for either KIIbv991 or L3, n = 2168). Furthermore,
there was no signi¢cant di¡erence in the levels of
expression of integrin subunits in transfected cells
expressing full-length KIIb (Fig. 2C) versus the
KIIbv991 truncation mutant (Fig. 2E).
Taken together, our measurements of integrin ex-
pression are fully consistent with the observations of
O’Toole et al. [46] that formation of the KIIbL3 com-
plex is a prerequisite for export of the integrin sub-
units to the cell surface.
3.2. Determination of integrin sedimentation velocity
by sucrose density gradient sedimentation
The goal of these experiments was to characterize
the solution structure of full-length native KIIbL3
and truncation mutant KIIbv991L3 by examining
their sedimentation velocity on sucrose density gra-
dients. Following procedures described by Ames et
al. [33], we ¢rst examined the sedimentation pro¢les
of proteins with known sedimentation coe⁄cients on
5^20% linear sucrose gradients prepared in HEPES-
bu¡ered octyl glucoside at pH 7.4. In addition to
myoglobin and hemoglobin, the other proteins used
as standards were labeled with a chromophore to
permit their detection by absorbance. The resultant
calibration pro¢le using data obtained in 15 such
gradients (Fig. 3A) exhibited the expected linear de-
pendence [33] of the sedimentation coe⁄cient on po-
sition within the gradient (expressed as the mass of
each fraction divided by the total mass of each gra-
dient). This calibration pro¢le was used to obtain
sedimentation coe⁄cients for both platelet-derived
(Fig. 3B) and recombinant integrin receptors (Fig.
3C).
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Fig. 3B depicts data obtained with KIIbL3 puri¢ed
from platelets, monitored by the intensity of Coo-
massie blue staining following sucrose density gra-
dient sedimentation and SDS^PAGE on each of
the resultant twelve fractions. Data for the KIIb sub-
unit are shown as open symbols, and a nearly super-
imposable sedimentation pro¢le resulted from mea-
suring the L3 subunit distribution (solid symbols), as
expected for the tightly associated KIIbL3 complex
[24].
These data were analyzed to obtain the weight-
average sedimentation coe⁄cient, Sw, according to
the following equation, where the sums are carried
out over each gradient fraction:
Sw 
X
SSignal=
X
Signal 1
By working at low protein concentrations we have
insured that the intensity of Coomassie blue staining
(or in subsequent experiments, the intensity of the
autoradiographs) is proportional to protein mass in
each sample, so that Eq. 1 returns a weight-average
sedimentation coe⁄cient [47].
For the data shown in Fig. 3B obtained with
KIIbL3 puri¢ed from platelets [36], analyzing the
KIIb subunit distribution yielded Sw = 8.1 S; a very
similar value of 8.3 S resulted from the L3 subunit
distribution. Results obtained from replicate experi-
ments with platelet KIIbL3 yielded Sw = 9.1 þ 1.0 S
(n = 4). A similar weight-average sedimentation coef-
¢cient resulted when epti¢batide was present in the
gradient, Sw = 9.0 þ 1.4 S (n = 2). In both cases, small
quantities of oligomers (V7% and V4%, respec-
tively) were observed sedimenting at s 12 S. The
distributions of sedimenting species we have obtained
here by sucrose density gradient sedimentation agree
quite well with our analytical ultracentrifugation
studies with platelet-derived KIIbL3, including even
the small shift toward a slower-sedimenting species in
the presence of epti¢batide [24,25].
Fig. 3. Measurements of integrin sedimentation velocity by su-
crose density gradient sedimentation. (A) Calibration pro¢le.
Mixture of proteins with known sedimentation coe⁄cients, each
containing either a natural or synthetic chromophore, were sep-
arated by sucrose density gradient sedimentation on 5^20% line-
ar sucrose gradients prepared in HEPES-bu¡ered octyl gluco-
side at pH 7.4. Absorbance measurements determined the
gradient fraction containing the peak protein concentration of
each standard. Linear regression was used to construct this
graph of Sedimentation Position (mass of peak fraction/total
gradient mass) versus Sedimentation Coe⁄cient. (B) Sedimenta-
tion velocity pro¢le for platelet-derived KIIbL3. A detergent-
solubilized membrane fraction of human blood platelets, en-
riched in the KIIbL3 integrin, was fractionated by sucrose den-
sity gradient sedimentation. Integrin concentrations within each
fraction were determined by SDS^PAGE followed by densito-
metric measurements (SigmaScan, Jandel) of the intensity of
Coomassie Brilliant blue-stained bands corresponding to the
KIIb (open symbols) and L3 (solid symbols) subunits. The
y-axis corresponds to the fraction of the total intensity in each
sample. Sedimentation Positions were converted to Sedimenta-
tion Coe⁄cients with the calibration pro¢le in A. (C) Sedimen-
tation velocity pro¢le for recombinant KIIbL3. A detergent-
solubilized lysate of 35S-labeled cells expressing full-length
KIIbL3 was fractionated by sucrose density gradient sedimenta-
tion, followed by immunoprecipitation with an KIIb-speci¢c
mAb, and detection with a PhosphorImager (Molecular Dy-
namics) to determine integrin KIIb subunit concentrations (ex-
pressed as a fraction of the total intensity) in each sample. Sed-
imentation Positions were converted to Sedimentation
Coe⁄cients with the calibration pro¢le in A. Triangles denote
the predicted sedimentation coe⁄cients for integrin protomers
(black), ligated ‘open’ conformers (gray), dimers (dark gray)
and trimers (light gray).
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Application of these same analyses to the data in
Fig. 3C, obtained with a lysate of 35S-labeled cells
expressing recombinant full-length KIIbL3, yielded
Sw = 9.4 S. We note the similarity of this pro¢le for
recombinant KIIbL3 to that obtained with platelet-
derived material (Fig. 3B). However, the recombi-
nant integrin also exhibited a smaller peak at V14
S. Interpretation of these results has been aided by
our molecular models and hydrodynamic calcula-
tions that predict the following sedimentation coe⁄-
cients for the KIIbL3 integrin (denoted by triangles in
Fig. 3C): ligand-free protomer, 8.4 S; ligated proto-
mer, 7.8 S; dimers, 10.8 S; trimers, 14.1 S [24]. Thus
the data in Fig. 3C can be described as two popula-
tions, with V79% of the material sedimenting in the
protomer/dimer fraction (peak at 7.9 S) and 21% as
trimers and larger oligomers (peak 15 S). Analysis of
data obtained in a series of experiments with re-
combinant full-length KIIbL3 showed that 73 þ 16%
sedimented in the protomer/dimer fraction (n = 6).
Experiments with KIIbv991L3 yielded comparable
results, with 65 þ 22% sedimenting as protomers/
dimers (n = 6).
3.3. E¡ects of ligation on the sedimentation pro¢les of
recombinant KIIbL3 and KIIbv991L3
Ligation-dependent changes in the sedimentation
pattern of recombinant KIIbL3 integrins are depicted
in Fig. 4. In each panel, and the ¢lled circles show
data obtained in the presence of a saturating concen-
tration of the model ligand epti¢batide [25^27]; the
open circles denote the distribution of radiolabeled
integrin species in the absence of ligands.
Fig. 4A depicts data obtained with recombinant
Table 1
Recombinant integrins: sedimentation coe⁄cient distributions
Sample Sw Protomer/dimer GSf Oligomer GSf % Oligomers No. of expts.
KIIbL3 11.3 þ 1.4 9.7 þ 1.0 15.4 þ 0.4 27 þ 16 6
+Epti¢batide 12.8 þ 2.0 7.1 þ 2.2 14.3 þ 0.9 79 þ 12 3
KIIbv991L3 11.2 þ 1.0 9.0 þ 1.3 15.1 þ 1.0 35 þ 22 6
+Epti¢batide 12.1 þ 1.7 7.2 þ 0.8 13.7 þ 0.2 73 þ 21 3
Sedimentation velocity pro¢les obtained with recombinant integrins by sucrose density gradient sedimentation were analyzed with Eq.
1 to determine the weight-average sedimentation coe⁄cient, Sw, for each condition. Each pro¢le was analyzed further to determine
the percentage of integrin species sedimenting as protomers (8 S) or dimers (11 S), and as higher order oligomers (s 12 S), as well as
the average sedimentation coe⁄cient, GSf, within each of these ranges.
Fig. 4. E¡ects of ligation on the sedimentation velocity pro¢les
of recombinant full-length integrin KIIbL3 and truncation mu-
tant KIIbv991L3. (A) Detergent-solubilized lysates of 35S-la-
beled cells expressing recombinant integrin KIIbL3 were incu-
bated with bu¡er or epti¢batide (30 WM) for 60 min, followed
by sucrose density sedimentation in the absence (open symbols)
or presence (solid symbols) of epti¢batide (10 WM). Gradient
samples were analyzed as described in the legend to Fig. 3C.
(B) Procedures described above were applied to truncation mu-
tant KIIbv991L3. Open symbols: ligand-free; closed symbols:
+epti¢batide. Triangles denote the predicted sedimentation coef-
¢cients for integrin protomers (black), ligated ‘open’ conformers
(gray), dimers (dark gray) and trimers (light gray).
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full-length KIIbL3, where ligation with epti¢batide
increased Sw to 13.5 S with s 90% now sedimenting
at s 14 S. Interestingly, a small amount of material
sedimented more slowly, a characteristic expected for
the ligand-occupied ‘open’ integrin conformer [24].
Fig. 4B shows the e¡ects of ligation on the trunca-
tion mutant KIIbv991L3, which in the presence of
epti¢batide also showed a dominant oligomer popu-
lation (78% at 13.7 S). This sample also contained a
slower sedimenting fraction (23% at 7.1 S).
Results we obtained in a series of tracer sedimen-
tation experiments with recombinant integrins are
summarized in Table 1. In the absence of ligands,
both native KIIbL3 (n = 6) and truncation mutant
KIIbv991L3 (n = 6) exhibited similar weight-average
sedimentation coe⁄cients at V11 S. In both cases,
V2/3 of the material sedimented in the protomer/
dimer fraction and the remainder as higher order
oligomers. However, our most striking observation
is that both the full-length integrin (n = 3) and the
truncation mutant (n = 3) showed a signi¢cant in-
crease (P6 0.05) in the oligomer fraction in the pres-
ence of epti¢batide, a high-a⁄nity ligand-mimetic
peptide [26,27].
These points are emphasized in Fig. 5 which de-
picts the distributions of sedimenting species for both
the full-length integrin and truncation mutant in the
presence and absence of ligand. Our results demon-
strate that both ligand-free integrins sedimented
mainly in the protomer/dimer fraction. In contrast,
ligation caused a 3-fold increase in the oligomer frac-
tion of the native receptor and a 2-fold increase with
the truncation mutant. This ¢gure also highlights the
presence of a small fraction of slower sedimenting
species with each ligated integrin.
4. Discussion
This investigation demonstrates that recombinant
integrin KIIbL3 can form clusters upon ligation of its
extracellular domain, even in the absence of the cy-
toplasmic region of its KIIb-subunit. Sucrose density
gradient sedimentation data demonstrated that in the
absence of ligands, both the full-length integrin and
truncation mutant KIIbv991L3 sedimented mainly as
integrin protomers and dimers [24]. Upon ligation
with epti¢batide, a high-a⁄nity ligand-mimetic that
occupies KIIbL3’s ¢brinogen binding site [26,27],
both recombinant integrins sedimented as activated
oligomers. Each ligated integrin also exhibited a
slower-sedimenting population upon ligation, consis-
tent with our postulate that receptor occupancy
shifts a conformational equilibrium toward an open
integrin with increased frictional drag [24]. These
new data support the concept that integrin activation
involves changes in both receptor conformation and
clustering [13,24]. Thus our ¢ndings provide new in-
sights into the structural basis of two complementary
Fig. 5. Distributions of integrin protomers and oligomers deter-
mined with full-length integrin KIIbL3 and truncation mutant
KIIbv991L3 in the absence (A) and presence of ligand (B). Sedi-
mentation velocity pro¢les measured with recombinant integrins
by sucrose density gradient sedimentation as described in the
legends to Figs. 3 and 4 were analyzed to determine the per-
centage of total integrin mass that sedimented as protomers
(8 S) or dimers (11 S), and as higher order oligomers (s 12 S).
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integrin activation mechanisms: inside-out and out-
side-in signaling [13^16].
As truncation mutant KIIbv991L3 has been de-
scribed as constitutively active [20,48], we originally
hypothesized that this integrin variant would exhibit
conformational characteristics of an open integrin
even in the absence of ligands. Consistent with this
postulate, comparison of the sedimentation pro¢les
for recombinant KIIbL3 and KIIbv991L3 suggests
that the equilibrium between open and closed integ-
rin conformers may have shifted somewhat toward
the activated form with the truncation mutant, even
in the absence of ligands. However, we also found
that ligation with epti¢batide was required to achieve
maximum activation of KIIbv991L3, de¢ned as in-
creased receptor oligomerization. Our data suggest
that rather than being ‘always-on’, truncation mu-
tant KIIbv991L3 may be constitutively ‘activated’
for inside-out signaling but is capable of further
structural changes upon ligand binding leading to
outside-in signaling.
In the absence of ligands, both full-length KIIbL3
and truncation mutant KIIbv991L3 exhibited distri-
butions of sedimenting species comparable to KIIbL3
puri¢ed from platelets. However, the ligated forms of
both recombinant integrins exhibited an increased
tendency to oligomerize compared to the integrin
puri¢ed from platelets. Di¡erences in the conditions
used for integrin isolation may have contributed to
these observations. For example, we have recently
obtained sedimentation equilibrium data showing
that clustering of KIIbL3 puri¢ed from platelets is
both temperature- and ligand-dependent (unpub-
lished observations). Since recombinant integrins
were isolated as lysates from cells grown overnight
at 37‡C, then applied to sucrose gradients, it is pos-
sible that temperature-induced clustering e¡ects con-
tributed to our observations. In addition, the concen-
trations of integrins were lower and non-integrin
proteins were higher in lysates of transfected cells
compared to detergent-solubilized platelet membrane
fractions, since KIIbL3 is the major platelet mem-
brane protein [11]. Thus interactions with other pro-
teins may have in£uenced the tendency of recombi-
nant integrins to form higher order oligomers.
In this context, we considered the possibility that
interactions with integrin-associated protein (IAP)
[49,50] or tetraspanins [51,52] could have in£uenced
our observations. We anticipated that vaccinia virus
infection used to express recombinant integrins
would quickly halt synthesis of host proteins and
that relatively little expression of radiolabeled non-
integrin proteins would result with our transfections.
Consistent with this expectation, immunoprecipita-
tion/autoradiography did not reveal signi¢cant quan-
tities of material at the expected molecular masses of
IAP (50 kDa) [49] or tetraspanins (such as CD9, 24
kDa [52]). We also note that both IAP and CD9
have considerably smaller molecular masses than
the 226 kDa KIIbL3 complex. Thus their association
with KIIbL3 would cause less than a 15% increase in
Sw (as shown by the Scheraga^Mandelkern equation,
Sw is proportional to M2=3 [53]), much smaller than
the ligation-dependent e¡ects we observed.
What are the implications of our new ¢ndings for
understanding integrin activation and integrin signal-
ing [13,14]? We have demonstrated that ligand-in-
duced integrin oligomerization is an intrinsic prop-
erty of the KIIbL3 complex, as it has been now been
observed with proteins isolated from platelets [24], as
well as integrins obtained by protein engineering (this
work). These observations support the concept of a
dynamic link between inside-out and outside-in in-
tegrin activation [13,19,54,55]. We have also demon-
strated ligand-dependent integrin self-association still
occurs with a truncation mutant lacking one cyto-
plasmic domain, indicating that this modi¢cation
does not abrogate the ligand-binding functions of
the receptor’s distant ectodomains. Perhaps our
most important ¢nding is the demonstration that
KIIb’s cytoplasmic region is not required for integrin
clustering. This suggests that integrin oligomerization
may be mediated through interactions between the
transmembrane regions of the KIIb and L3 subunits
rather than their cytoplasmic tails. Alternatively, the
now unpaired L3 intracellular domains may be re-
sponsible for integrin self-association. Our ¢ndings
are especially interesting in light of the recent dem-
onstration of the central role of the L3 cytoplasmic
domain of integrin KIIbL3 in outside-in signaling
[56,57].
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